Twenty-First Century Fox (NASDAQ:FOXA)- Unusual Stocks Mover Hurt By Street Views: Harte Hanks, Inc. (NYSE:HHS)

Twenty-First Century Fox, Inc. (NASDAQ:FOXA) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 2.66% to $27.04. New sexual harassment accusations against former Fox News network chief Roger Ailes were revealed in a lawsuit filed against 21st Century Fox on Monday. The lawsuit comes just months after Fox News agreed to pay $20 million to settle separate allegations of sexual harassment of female staff at Fox News by Ailes.

The federal discrimination lawsuit filed in New York alleges that Ailes offered Lidia Curanaj, whose legal name is LidijaUjkic, an interview to join the Fox News Network after meeting her at a dinner in 2011. After being interviewed in a group setting, Ailes invited her to a private interview, the complaint said. He then told her it was “important [for female talent] to look good from head to toe,” and asked her to stand and turn around for him. The share price of FOXA attracts active investors, as stock price of week volatility recorded 5.02%. The stock is going forward to its 52-week low with 20.90% and lagging behind from its 52-week high price with -12.81%.

Harte Hanks, Inc. (NYSE:HHS) [Trend Analysis] moved up reacts as active mover, shares an advance 4.17% to traded at $1.50 and the percentage gap between open changing to regular change was -0.69%. Harte Hanks (NYSE:HHS) declared that its Executive Vice President and Chief Financial Officer, Doug Shepard, has resigned from the company, effective December 31, 2016, to pursue another professional opportunity.

Mr. Shepard, who has served as the company’s EVP and CFO since 2007, also will provide transitional consultative services to the company in 2017. While the company conducts a formal search for his replacement, Robert Munden, the company’s EVP and General Counsel, will serve as interim CFO, and Scott Hamilton will coordinate the company’s investor relations program.

Commenting on the transition, Chief Executive Officer Karen Puckett said, “On behalf of the Board of Directors and the management team, I want to thank Doug for his nine years of dedicated service. Doug has built a strong finance team that is ready and capable as we continue Harte Hanks’ transformation. He has helped position us well. With the declared sale of our Trillium Software unit and the expected retirement of our current credit facility, we will have strengthened the company’s financial position and our ability to focus on our strategic goals. We wish Doug all the best.” The firm’s current ratio calculated as 1.70 for the most recent quarter. The firm past twelve months price to sales ratio was 0.22 and price to cash ratio remained 13.22. As far as the returns are concern, the return on equity was recorded as -8.00% and return on investment was -76.00% while its return on asset stayed at -2.60%. The firm has total debt to equity ratio measured as 0.50.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *